Benoı̂t Blanchet

5.2k total citations
139 papers, 3.6k citations indexed

About

Benoı̂t Blanchet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Benoı̂t Blanchet has authored 139 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 46 papers in Pulmonary and Respiratory Medicine and 39 papers in Molecular Biology. Recurrent topics in Benoı̂t Blanchet's work include Colorectal Cancer Treatments and Studies (25 papers), Renal cell carcinoma treatment (15 papers) and Cancer Treatment and Pharmacology (15 papers). Benoı̂t Blanchet is often cited by papers focused on Colorectal Cancer Treatments and Studies (25 papers), Renal cell carcinoma treatment (15 papers) and Cancer Treatment and Pharmacology (15 papers). Benoı̂t Blanchet collaborates with scholars based in France, United States and Switzerland. Benoı̂t Blanchet's co-authors include François Goldwasser, Michel Vidal, Pascaline Boudou‐Rouquette, Romain Coriat, Michel Tod, Stanislas Ropert, Olivier Mir, Audrey Thomas‐Schoemann, Bertrand Billemont and François Goldwasser and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Benoı̂t Blanchet

134 papers receiving 3.5k citations

Peers

Countries citing papers authored by Benoı̂t Blanchet

Since Specialization

Citations

This map shows the geographic impact of Benoı̂t Blanchet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoı̂t Blanchet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoı̂t Blanchet more than expected).

Fields of papers citing papers by Benoı̂t Blanchet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoı̂t Blanchet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoı̂t Blanchet. The network helps show where Benoı̂t Blanchet may publish in the future.

Co-authorship network of co-authors of Benoı̂t Blanchet

This figure shows the co-authorship network connecting the top 25 collaborators of Benoı̂t Blanchet. A scholar is included among the top collaborators of Benoı̂t Blanchet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoı̂t Blanchet. Benoı̂t Blanchet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Droplet Digital PCR Assay for Detection and Monitoring of Universally Methylated ctDNA in Patients with Sarcoma 2025 ·Clinical Cancer Research ·(unknown), Valérie Taly, Camille Tlemsani, Pascaline Boudou‐Rouquette, (unknown), (unknown), (unknown), (unknown), Béatrice Parfait, (unknown), (unknown), Fréderique Larousserie, (unknown), (unknown), Benoı̂t Blanchet, (unknown), François Goldwasser, Pierre Laurent‐Puig, Jérôme Alexandre, Guillaume Beinse	0
2	Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients 2024 ·British Journal of Cancer ·Alicja Puszkiel, (unknown), (unknown), (unknown), Jennifer Arrondeau, Pascaline Boudou‐Rouquette, (unknown), Joe‐Elie Salem, Xavier Declèves, Michel Vidal, N. Kramkimel, Sarah Guégan, S. Aractingi, Olivier Huillard, Jérôme Alexandre, Marie Wislez, François Goldwasser, Benoı̂t Blanchet	7
3	Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer 2023 ·Cancers ·Florent Puisset, (unknown), Loı̈c Mourey, Damien Pouessel, Benoı̂t Blanchet, Étienne Chatelut, Christine Chevreau	5
4	LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing’s Syndrome 2023 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Fidéline Bonnet-Serrano, (unknown), Nihel Khoudour, Alicja Puszkiel, Lionel Groussin, Michel Vidal, Xavier Declèves, Jérôme Bertherat, Benoı̂t Blanchet	4
5	Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection 2023 ·Cancer Chemotherapy and Pharmacology ·(unknown), Alicja Puszkiel, Pascaline Boudou‐Rouquette, (unknown), Jérôme Alexandre, (unknown), (unknown), Benoı̂t Blanchet, Rui Batista, François Goldwasser, (unknown)	1
6	Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer 2022 ·Pharmaceutics ·Perrine Courlet, (unknown), (unknown), Athina Stravodimou, (unknown), Haïthem Chtioui, Isabella Locatelli, Laurent A. Décosterd, (unknown), Benoı̂t Blanchet, Jérôme Alexandre, Dorothea Wagner, Khalil Zaman, Marie Paule Schneider, Monia Guidi, Chantal Csajka	6
7	Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients 2022 ·Pharmaceutics ·(unknown), Pascaline Boudou‐Rouquette, Anne Jouinot, (unknown), (unknown), Nihel Khoudour, Camille Tlemsani, Jonathan Chauvin, Audrey Thomas‐Schoemann, François Goldwasser, Benoı̂t Blanchet, Jérôme Alexandre	6
8	Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer 2022 ·Pharmaceutics ·(unknown), Alicja Puszkiel, (unknown), (unknown), Céline Narjoz, Jennifer Arrondeau, Vincent Fallet, Nihel Khoudour, Monia Guidi, Michel Vidal, Xavier Declèves, Chantal Csajka, Jérôme Alexandre, Jacques Cadranel, Elizabeth Fabre, Marie Wislez, François Goldwasser, Benoı̂t Blanchet	18
9	Low-dose mycophenolate mofetil improves survival in a murine model of Staphylococcus aureus sepsis by increasing bacterial clearance and phagocyte function 2022 ·Frontiers in Immunology ·Fanny Alby‐Laurent, Nadia Belaïdouni, Benoı̂t Blanchet, Christophe Rousseau, Jean‐François Llitjos, Sylvia Sanquer, Jean-Paul Mira, Frédéric Pène, Julie Toubiana, Jean‐Daniel Chiche	3
10	Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study 2021 ·Pharmaceuticals ·(unknown), Alicja Puszkiel, Benoı̂t Blanchet, (unknown), Nicolas Delanoy, Jacques Médioni, Claire Gervais, (unknown), Nihel Khoudour, Patricia Pautier, Alexandra Léary, (unknown), Laure Hirsch, François Goldwasser, Jérôme Alexandre, Guillaume Beinse	16
11	Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study 2021 ·Pharmaceuticals ·(unknown), Nihel Khoudour, (unknown), Dorothée Lebert, (unknown), Fabienne Thomas, David Ternant, Bruno Lacarelle, Jérôme Guitton, Joseph Ciccolini, Benoı̂t Blanchet	19
12	Genetic determinism of boar taint and relationship with growth traits, meat quality and lesions 2020 ·animal ·(unknown), Armelle Prunier, (unknown), (unknown), Benoı̂t Blanchet, Catherine Larzul	13
13	The impact of body composition parameters on severe toxicity of nivolumab 2019 ·European Journal of Cancer ·Laure Hirsch, Audrey Bellesœur, Pascaline Boudou‐Rouquette, Jennifer Arrondeau, Audrey Thomas‐Schoemann, Julien Kirchgesner, Claire Gervais, Anne Jouinot, Jeanne Chapron, Frédérique Giraud, Marie Wislez, Jérôme Alexandre, Benoı̂t Blanchet, François Goldwasser	33
14	Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients 2019 ·Clinical Therapeutics ·Marie Allard, Alicja Puszkiel, Filomena Conti, L Chevillard, Nassim Kamar, Gaëlle Noé, Mélanie White‐Koning, Audrey Thomas‐Schoemann, Tabassome Simon, Michel Vidal, Yvon Calmus, Benoı̂t Blanchet	6
15	Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients 2017 ·Journal of Pharmaceutical and Biomedical Analysis ·Alicja Puszkiel, Gaëlle Noé, Pascaline Boudou‐Rouquette, Chloé Le Cossec, Jennifer Arrondeau, (unknown), Audrey Thomas‐Schoemann, Jérôme Alexandre, Michel Vidal, François Goldwasser, Benoı̂t Blanchet	37
16	Inhibiteurs de tyrosine kinase ciblant l’angiogenèse et sujets âgés : tolérance, évaluation pré-thérapeutique et gestion des effets indésirables 2016 ·Bulletin du Cancer ·Marie Bretagne, Pascaline Boudou‐Rouquette, Olivier Huillard, Audrey Thomas‐Schoemann, (unknown), (unknown), Jennifer Arrondeau, Camille Tlemsani, Anatole Cessot, Laure Cabanes, Benoı̂t Blanchet, Romain Coriat, Jérôme Alexandre, François Goldwasser	4
17	Evaluation of the interindividual variability in plasma nivolumab level in non-small-lung cancer outpatients: preliminary results 2016 ·Annals of Oncology ·Alicja Puszkiel, Gaëlle Noé, Pascaline Boudou‐Rouquette, Chloé Le Cossec, Jennifer Arrondeau, (unknown), Jérôme Alexandre, Michel Vidal, François Goldwasser, Benoı̂t Blanchet	2
18	Influence of Burns on Pharmacokinetics and Pharmacodynamics of Drugs Used in the Care of Burn Patients 2008 ·Clinical Pharmacokinetics ·Benoı̂t Blanchet, Vincent Jullien, Christophe Vinsonneau, Michel Tod	106
19	Étude de l'efficacité du vaccin Spirolept®contre la leptospirose par la protection passive de rongeurs de laboratoire 2004 ·Médecine et Maladies Infectieuses ·(unknown), (unknown), Benoı̂t Blanchet, (unknown), (unknown), G. André‐Fontaine	11
20	Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression 2003 ·Experimental Hematology ·Emiko Komura, Hédia Chagraoui, (unknown), Benoı̂t Blanchet, Paulo De Sepulveda, Frédéric Larbret, Jérôme Larghero, Michel Tulliez, Najet Debili, William Vainchenker, Stéphane Giraudier	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact